This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PANCREAS_EXALLC for full statistics.
Malignant neoplasm of pancreas
C3_PANCREAS
Malignant Pancreatic Neoplasm: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2331 |
4. Check minimum number of eventsNone |
2331 |
5. Include endpointsNone |
2331 |
6. Filter based on genotype QC (FinnGen only) |
2331 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of pancreas
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
- Adenocarcinoma and ductal carcinoma of pancreas
- Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
- Adenocarcinoma of pancreas
- Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)
- Neuroendocrine tumor and carcinoma of pancreas
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2331 | 940 | 1391 |
| Unadjusted period prevalence (%) | 0.50 | 0.32 | 0.61 |
| Median age at first event (years) | 71.20 | 71.16 | 71.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2061
- Matched controls
- 20609
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
30.2
323.0
1267
1035
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
142.4
323.0
569
55
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
70.0
323.0
770
174
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
881.7
323.0
907
18
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
655.5
323.0
332
6
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
21.0
323.0
528
332
A04AA02
ATC
granisetron; systemic, transdermal
17.7
323.0
626
496
A09AA02
ATC
multienzymes (lipase, protease etc.)
71.6
323.0
630
126
A03FA01
ATC
metoclopramide; systemic, rectal
9.1
323.0
1140
2460
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
323.0
583
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
213.2
323.0
339
19
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
898.8
323.0
1186
31
N02AA05
ATC
oxycodone; systemic
7.9
323.0
989
2158
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
323.0
478
*
Z51.5
ICD-10 Finland
Palliative care
11.8
313.1
634
750
UJK02
NOMESCO Finland
ERCP
23.5
295.1
436
233
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
509.3
274.7
268
6
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
35.1
272.3
357
122
H02AB02
ATC
dexamethasone; systemic
8.7
267.2
651
1038
K83.1
ICD-10 Finland
Obstruction of bile duct
44.6
261.9
325
86
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
55.3
257.9
307
65
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
21.6
235.5
356
197
L01BC06
ATC
capecitabine; oral
15.8
227.8
389
299
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
1105.1
208.0
200
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
13.0
203.4
379
351
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
44.0
194.6
242
62
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
25.4
185.4
265
119
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
+∞
173.4
164
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
13.2
167.7
308
271
D76
ICPC
Malignant neoplasm pancreas
352.6
161.4
161
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.8
160.0
369
499
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
21.2
158.9
240
127
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.8
152.3
382
587
JN4CD
NOMESCO Finland
Very extensive body CT
8.8
135.7
309
403
A04AA01
ATC
ondansetron; systemic, rectal
6.9
130.0
353
600
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
17.0
129.3
211
137
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
128.5
122
*
8000/3-C25.0
ICD-O-3
Neoplasm, malignant of head of pancreas
+∞
121.0
115
*
JN4BD
NOMESCO Finland
Extensive body CT
4.4
116.8
494
1388
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
32.1
114.0
152
51
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
175.4
111.5
116
7
R4190
NOMESCO Finland
Nutritional therapy
12.8
109.3
201
172
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
13.6
104.6
187
150
JLC10
NOMESCO Finland
Distal pancreatectomy
87.8
104.3
116
14
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
15.4
102.7
174
123
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
1016.0
100.0
97
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
8.7
99.9
226
286
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
983.0
96.8
94
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
67.6
94.7
109
17
JAH01
NOMESCO Finland
Laparoscopy
8.5
93.6
215
278
A06AH03
ATC
naloxegol; oral
20.3
91.4
139
73
C25
ICD-10 Finland
Malignant neoplasm of pancreas
456.8
88.9
88
*
K83.0
ICD-10 Finland
Cholangitis
14.1
88.0
154
117
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.4
87.1
188
218
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.5
85.5
338
866
JDE00
NOMESCO Finland
Gastrojejunostomy
83.0
84.9
95
12
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.7
82.7
223
365
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
61.5
80.5
94
16
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
80.3
785
3912
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.7
79.4
396
1246
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
26.3
78.6
110
44
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.8
78.5
285
666
JN4AD
NOMESCO Finland
Body CT examination
4.2
77.7
323
864
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
89.8
77.6
86
10
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
21.1
73.4
110
55
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
26.4
68.8
96
38
R18
ICD-10 Finland
Ascites
10.2
68.6
140
146
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
56.1
68.5
81
15
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
7.3
66.6
167
245
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.0
66.1
290
808
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
66.0
63
*
8140/3-C25.2
ICD-O-3
Adenocarcinoma, NOS, of tail of pancreas
+∞
66.0
63
*
A98
ICPC
Health maint/preventive medicine
0.4
65.3
1175
15518
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
12.6
64.4
118
99
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
62.9
421
1620
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
25.5
62.5
88
36
JMA10
NOMESCO Finland
Transabdominal total splenectomy
24.2
60.2
86
37
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
59.7
57
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
58.7
244
644
WZC30
NOMESCO Finland
Teaching
3.0
57.5
387
1488
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
16.7
57.5
93
58
B01AB10
ATC
tinzaparin; parenteral
4.0
57.3
247
673
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.9
56.4
198
441
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
283.6
54.4
55
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
18.6
54.0
84
47
L03AA02
ATC
filgrastim; parenteral
7.3
53.5
133
192
R50.9
ICD-10 Finland
Fever, unspecified
2.8
53.4
411
1711
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
53.3
387
1556
A10AE04
ATC
insulin glargine; parenteral
3.1
52.9
322
1151
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.8
52.3
103
100
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
52.3
50
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
51.8
265
832
8140/3-C25.1
ICD-O-3
Adenocarcinoma, NOS, of body of pancreas
+∞
49.2
47
*
H01CB03
ATC
lanreotide; parenteral
54.2
48.9
58
11
B01AB05
ATC
enoxaparin; parenteral
2.1
48.4
752
4425
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
8.3
48.2
110
139
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
87.2
46.0
51
6
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
46.0
44
*
WW500
NOMESCO Finland
Blood transfusion
4.7
45.6
164
373
8010/3-C25.9
ICD-O-3
Carcinoma, NOS, of pancreas, NOS
+∞
45.0
43
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.7
44.5
117
183
1CD01
NOMESCO Finland
NA
58.0
43.5
51
9
191
Kela drug reimbursment
Erlotinib
39.6
43.0
54
14
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
426.1
42.3
42
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
94.1
41.9
46
5
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
41.6
728
4428
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
20.6
41.5
62
31
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
67.1
40.2
46
7
JAH00
NOMESCO Finland
Laparotomy
5.3
40.2
128
255
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
394.7
39.2
39
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
20.5
38.9
58
29
J01MA12
ATC
levofloxacin; systemic
2.2
38.7
501
2677
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
38.4
699
4285
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.2
38.3
95
137
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
22.6
38.0
55
25
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
36.5
516
2853
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
61.2
36.2
42
7
WX004
NOMESCO Finland
Patient-controlled sedation
18.8
35.8
55
30
H01CB02
ATC
octreotide; parenteral
30.0
35.2
47
16
A04AA55
ATC
palonosetron, combinations; systemic
6.7
34.7
91
142
A06AD11
ATC
lactulose; oral
2.1
34.7
466
2514
1570A
ICD-9 Finland
Malignant neoplasm of pancreas, Head of pancreas
94.2
33.8
37
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
33.8
358
1732
ZX122
NOMESCO Finland
Intra-arterial
17.5
33.7
53
31
L01AX03
ATC
temozolomide; systemic
16.4
32.9
53
33
L01XE03
ATC
[U] erlotinib; oral
38.0
32.5
41
11
N02AX02
ATC
tramadol; systemic, rectal
1.8
31.9
924
6517
SPAT1109
SPAT
Analgesia with portable analgesic pump
12.4
31.5
57
47
8000/3-C25.1
ICD-O-3
Neoplasm, malignant of body of pancreas
+∞
31.3
30
*
A02BC02
ATC
pantoprazole; systemic
1.7
31.3
1317
10386
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
29.8
30.8
41
14
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.2
30.2
68
85
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
29.5
284
1306
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.4
28.6
107
253
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.4
28.6
77
125
A04AD12
ATC
aprepitant; systemic
6.4
28.2
75
120
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
28.0
642
4163
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
17.3
28.0
44
26
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.5
27.9
74
118
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
47.8
27.5
33
7
ZX120
NOMESCO Finland
Intravenous
2.4
27.0
250
1123
K86.1
ICD-10 Finland
Other chronic pancreatitis
9.1
27.0
57
64
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
10.1
27.0
54
55
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
26.8
392
6184
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
141.8
26.7
28
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
34.5
26.5
34
10
K85.8
ICD-10 Finland
Other acute pancreatitis
13.4
26.5
46
35
SPAT1053
SPAT
Memory test
0.4
24.9
120
2715
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
5.3
24.6
77
151
L03AA13
ATC
pegfilgrastim; parenteral
3.9
24.3
103
274
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
24.1
319
5205
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.8
23.7
60
90
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
23.7
121
376
B01AB04
ATC
dalteparin; parenteral
2.9
23.4
150
546
JLA00
NOMESCO Finland
Exploration of pancreas
65.7
22.9
26
*
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
84.4
22.7
25
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
22.7
230
4061
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
22.6
662
8929
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
22.4
382
2217
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
45.5
22.4
27
6
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
45.5
22.4
27
6
E34.0
ICD-10 Finland
Carcinoid syndrome
27.6
22.3
30
11
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
22.2
106
2415
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
22.0
149
559
8000/3-C25.2
ICD-O-3
Neoplasm, malignant of tail of pancreas
+∞
21.9
21
*
JLA10
NOMESCO Finland
Biopsy of pancreas
81.0
21.7
24
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
21.5
146
548
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
50.6
21.1
25
5
P20
ICPC
Memory disturbance
0.4
20.8
87
2087
N02AA01
ATC
morphine; systemic, rectal
4.8
20.8
70
150
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
77.6
20.7
23
*
K86.8
ICD-10 Finland
Other specified diseases of pancreas
18.5
20.4
31
17
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
10.7
19.9
38
36
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
29.2
19.6
26
9
M25.5
ICD-10 Finland
Pain in joint
0.5
19.3
167
3110
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
19.0
571
3920
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
18.8
18
*
158
Kela drug reimbursment
Everolimus
70.5
18.7
21
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
17.3
18.7
29
17
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
23.9
18.6
26
11
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
18.4
94
2097
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
18.3
155
664
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
44.4
18.2
22
5
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.7
18.0
61
132
M79.6
ICD-10 Finland
Pain in limb
0.6
17.5
292
4552
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
17.3
45
71
TJA10
NOMESCO Finland
Laparocentesis
18.8
17.3
26
14
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
42.4
17.3
21
5
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
17.3
27
1024
N05AD01
ATC
haloperidol; systemic
2.9
17.1
106
378
WX320
NOMESCO Finland
Spinalanesthesy
0.5
17.1
177
3137
N06DX01
ATC
memantine; oral
0.3
16.9
32
1100
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
16.8
564
7553
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
16.7
426
6037
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
16.6
295
4535
A79
ICPC
Malignancy NOS
4.6
16.6
57
126
WX610
NOMESCO Finland
Patient controlled analgesia
15.5
16.2
26
17
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
16.1
156
2820
A10BA02
ATC
metformin; oral
1.5
15.9
627
4560
K02.1
ICD-10 Finland
Caries of dentine
0.6
15.7
481
6583
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
15.7
485
3325
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
9.3
15.7
32
35
8249/3-C25.2
ICD-O-3
Neuroendocrine tumor, grade 2 of tail of pancreas
+∞
15.6
15
*
ZX121
NOMESCO Finland
Central venous catheter
17.3
15.6
24
14
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.7
15.6
39
59
C10AA07
ATC
rosuvastatin; oral
0.5
15.5
190
3219
1579X
ICD-9 Finland
Malignant neoplasm of pancreas, Pancreas, part unspecified
161.2
15.5
16
*
A41.8
ICD-10 Finland
Other specified sepsis
4.0
15.4
61
155
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
7.7
15.4
35
46
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
17.9
15.1
23
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
15.1
351
2223
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
45.3
15.1
18
*
A10AE05
ATC
insulin detemir; parenteral
2.4
15.1
131
569
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
15.0
237
3764
C10AA05
ATC
atorvastatin; oral
0.7
15.0
468
6396
WX002
NOMESCO Finland
Sedation and analgesia
1.6
14.9
401
2648
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.4
14.8
70
1607
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.7
14.8
458
6271
L03
ICPC
Low back symptom/complaint
0.5
14.8
151
2691
340
Kela drug reimbursment
Everolimus
+∞
14.6
14
*
8246/3-C25.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of pancreas, NOS
+∞
14.6
14
*
K86.3
ICD-10 Finland
Pseudocyst of pancreas
12.0
14.6
26
22
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
14.4
242
3790
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.0
14.1
56
143
T73
ICPC
Neoplasm endocrine other/unspecified
42.8
14.1
17
*
B01AF02
ATC
apixaban; oral
0.4
14.1
62
1465
L15
ICPC
Knee symptom/complaint
0.5
13.8
131
2389
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
9.1
13.7
28
31
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.6
13.7
311
4553
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
75.6
13.6
15
*
G04BD12
ATC
mirabegron; oral
0.4
13.6
56
1360
DAX08
NOMESCO Finland
Fitting of hearing aid
0.2
13.5
10
588
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
13.4
430
5878
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.7
13.4
503
6672
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.6
13.4
178
2958
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.2
13.3
11
603
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
13.3
92
353
K31.5
ICD-10 Finland
Obstruction of duodenum
21.3
13.3
19
9
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
13.3
95
371
R11
ICD-10 Finland
Nausea and vomiting
2.1
13.3
162
820
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
13.3
354
5017
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
13.2
222
3483
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
13.1
481
3418
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
12.9
239
3666
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
50.3
12.8
15
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.4
12.7
62
189
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.6
12.7
94
374
R03AC02
ATC
salbutamol; inhalant
0.7
12.6
557
7197
H81
ICPC
Excessive ear wax
0.5
12.6
141
2461
JKD00
NOMESCO Finland
Anastomosis of gallbladder to jejunum
70.3
12.6
14
*
Z01.2
ICD-10 Finland
Dental examination
0.6
12.6
299
4347
R83
ICPC
Respiratory infection other
0.5
12.6
74
1572
1571A
ICD-9 Finland
Malignant neoplasm of pancreas, Body of pancreas
+∞
12.5
12
*
C25.3
ICD-10 Finland
Malignant neoplasm: Pancreatic duct
+∞
12.5
12
*
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
20.2
12.5
18
9
197
Kela drug reimbursment
Sunitinib
13.2
12.4
21
16
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
12.1
194
3082
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
12.0
327
4632
207
Kela drug reimbursment
Chronic arrhythmias
0.6
12.0
150
2543
JKA20
NOMESCO Finland
Cholecystectomy
2.6
12.0
86
337
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
11.9
45
1129
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.1
11.9
65
216
L01XE10
ATC
[U] everolimus; oral
46.9
11.9
14
*
TPX15
NOMESCO Finland
Removal of vascular injection port
9.0
11.7
24
27
L08
ICPC
Shoulder symptom/complaint
0.5
11.7
131
2284
E16.10
ICD-10 Finland
Hyperinsulinism
65.3
11.6
13
*
8240/3-C25.2
ICD-O-3
Neuroendocrine tumor, NOS, of tail of pancreas
+∞
11.5
11
*
E13
ICD-10 Finland
Other specified diabetes mellitus
13.7
11.4
19
14
WX892
NOMESCO Finland
Monitored bed care
1.9
11.4
164
886
XF612
NOMESCO Finland
Measurement of central venous pressure
15.1
11.3
18
12
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
35.2
11.3
14
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.2
11.2
41
98
L13
ICPC
Hip symptom/complaint
0.5
11.2
109
1978
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.5
11.2
100
1859
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
12.8
11.1
19
15
I81
ICD-10 Finland
Portal vein thrombosis
8.9
10.8
22
25
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
28.2
10.7
14
5
H26.4
ICD-10 Finland
After-cataract
0.5
10.7
68
1407
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
13.0
10.6
18
14
L30.9
ICD-10 Finland
Dermatitis, unspecified
0.5
10.6
110
1962
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.3
10.5
19
17
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
10.5
220
1345
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.6
10.5
134
2261
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
10.4
36
82
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.5
10.4
83
1600
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
10.4
174
992
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
16.1
10.3
16
10
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.4
10.3
39
981
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
32.7
10.3
13
*
D13
ICPC
Jaundice
32.7
10.3
13
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
18.9
10.3
15
8
JN4DD
NOMESCO Finland
Scout CT scan of torso
18.9
10.3
15
8
WX402
NOMESCO Finland
General anaesthesia
1.6
10.2
250
1597
N40
ICD-10 Finland
Hyperplasia of prostate
0.7
10.2
313
4349
T90
ICPC
Diabetes non-insulin dependent
1.5
10.1
463
3423
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
4.5
10.1
34
76
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
10.1
155
859
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
11.3
10.0
18
16
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
10.0
97
1767
H02
ICPC
Hearing complaint
0.5
9.9
95
1734
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.9
9.9
39
101
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
6.3
9.8
25
40
N06DA02
ATC
donepezil; oral
0.4
9.8
35
900
M01AH05
ATC
etoricoxib; oral
0.7
9.8
612
7562
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
9.6
9.8
19
20
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.6
9.7
198
2991
XKD00
NOMESCO Finland
Uroflowmetry
0.6
9.7
187
2858
WW200
SPAT
NA
0.4
9.6
32
845
R5140
NOMESCO Finland
Monitoring the use of the aid
0.4
9.6
53
1155
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
9.5
938
10880
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
9.5
286
4000
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
0.3
9.5
27
766
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.3
9.4
21
668
PHN72
NOMESCO Finland
Plastic repair of superior mesenteric or portal vein
+∞
9.4
9
*
PHC71
NOMESCO Finland
Suture of mesenteric or portal vein
+∞
9.4
9
*
8480/3-C25.9
ICD-O-3
Mucinous adenocarcinoma of pancreas, NOS
+∞
9.4
9
*
1572A
ICD-9 Finland
Malignant neoplasm of pancreas, Tail of pancreas
+∞
9.4
9
*
8010/3-C25.0
ICD-O-3
Carcinoma, NOS, of head of pancreas
+∞
9.4
9
*
V03AF03
ATC
calcium folinate; systemic
12.4
9.4
16
13
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.5
9.3
100
1767
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
9.2
185
1117
L17
ICPC
Foot/toe symptom/complaint
0.6
9.2
217
3186
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
0.7
9.2
365
4863
T89
ICPC
Diabetes insulin dependent
2.7
9.1
59
222
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.0
9.0
34
85
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
24.1
8.9
12
5
R06AX27
ATC
desloratadine; oral
0.6
8.9
147
2330
Z31.5
ICD-10 Finland
Genetic counselling
2.8
8.8
56
206
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.7
8.8
356
4732
I48.2
ICD-10 Finland
Chronic atrial fibrillation
0.1
8.8
*
307
JFC00
NOMESCO Finland
Entero-enterostomy
10.7
8.8
16
15
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
4.6
8.8
29
64
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.5
8.7
51
1089
SPAT1262
SPAT
Handing over of treatment supplies
1.5
8.7
356
2565
SPAT1043
SPAT
Audiometry
0.5
8.7
78
1452
325
Kela drug reimbursment
Erlotinib
50.2
8.7
10
*
L57.0
ICD-10 Finland
Actinic keratosis
0.5
8.7
74
1398
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.7
8.7
529
6596
AA1AD
NOMESCO Finland
CT of head and brain
0.7
8.6
270
3752
DFF15
NOMESCO Finland
Speech audiometry
0.3
8.5
16
550
R05
ICD-10 Finland
Cough
0.6
8.5
143
2258
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
8.5
77
346
R42
ICD-10 Finland
Dizziness and giddiness
0.7
8.4
225
3224
L82
ICD-10 Finland
Seborrhoeic keratosis
0.6
8.4
115
1911
6706
FHL
Pancreatic homeectomy (eg Whipple)
90.4
8.4
9
*
8500/3-C25.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of body of pancreas
+∞
8.3
8
*
8249/3-C25.0
ICD-O-3
Neuroendocrine tumor, grade 2 of head of pancreas
+∞
8.3
8
*
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
8.3
18
578
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
6.2
8.3
21
34
ZX095
NOMESCO Finland
Combined chemoradiotherapy
6.2
8.3
21
34
K85
ICD-10 Finland
Acute pancreatitis
2.9
8.3
48
167
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.5
8.2
69
1311
C10AC01
ATC
colestyramine; oral
2.7
8.2
53
198
J01CA04
ATC
amoxicillin; systemic
0.8
8.2
1085
12219
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.6
8.2
112
1859
J94.8
ICD-10 Finland
Other specified pleural conditions
2.8
8.2
50
182
B01AC04
ATC
clopidogrel; oral
0.6
8.2
176
2633
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.6
8.1
106
1785
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
8.1
342
4521
S18
ICPC
Laceration/cut
0.7
8.1
499
6226
A21
ICPC
Risk factor for malignancy
17.2
8.1
12
7
XCW99
NOMESCO Finland
Other investigative procedure of eye
0.5
8.0
82
1469
R05
ICPC
Cough
0.6
8.0
165
2494
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.0
8.0
30
76
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
7.9
355
4649
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
0.4
7.9
30
749
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.3
7.9
38
118
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
7.9
70
312
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
7.9
827
6971
F51.0
ICD-10 Finland
Nonorganic insomnia
0.5
7.8
50
1036
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
10.8
7.8
14
13
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.5
7.8
60
1166
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.5
7.8
48
1002
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.4
7.7
26
684
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
7.7
305
4077
H25.8
ICD-10 Finland
Other senile cataract
0.6
7.6
110
1802
ZXA10
NOMESCO Finland
Bilateral
0.6
7.6
179
2635
KA1FN
NOMESCO Finland
Isotope renography
4.9
7.6
23
47
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.0
7.6
28
70
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
7.6
102
541
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.7
7.5
492
6105
H13
ICPC
Plugged feeling ear
0.6
7.5
177
2603
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.3
7.5
26
61
WX290
NOMESCO Finland
Other blockade of nerve
0.7
7.5
307
4088
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
7.5
20
582
K86.2
ICD-10 Finland
Cyst of pancreas
4.4
7.4
25
57
JLB42
NOMESCO Finland
Transduodenal endoscopic dilatation of pancreatic duct
80.4
7.4
8
*
6672
FHL
Cholecocenterostomy
80.4
7.4
8
*
R06.0
ICD-10 Finland
Dyspnoea
0.7
7.4
269
3649
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.7
7.3
213
3013
WX882
NOMESCO Finland
High dependency care
2.4
7.3
59
252
R10.0
ICD-10 Finland
Acute abdomen
2.4
7.3
56
233
8500/3-C25.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of tail of pancreas
+∞
7.3
7
*
8249/3-C25.1
ICD-O-3
Neuroendocrine tumor, grade 2 of body of pancreas
+∞
7.3
7
*
JLA20
NOMESCO Finland
Needle biopsy of pancreas
+∞
7.3
7
*
9680/3-C25.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pancreas, NOS
+∞
7.3
7
*
V03AH01
ATC
diazoxide; systemic
+∞
7.3
7
*
M48.0
ICD-10 Finland
Spinal stenosis
0.6
7.2
109
1770
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
0.5
7.2
59
1127
KMAK
NOMESCO Finland
NA
0.7
7.2
487
6020
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.3
7.2
20
572
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.5
7.2
76
1351
R74
ICPC
Upper respiratory infection acute
0.6
7.2
140
2140
EBA00
NOMESCO Finland
Extraction of tooth
0.7
7.1
284
3800
D19
ICPC
Teeth/gum symptom/complaint
0.6
7.1
164
2428
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
20.1
7.1
10
5
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
7.9
7.1
15
19
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.4
7.1
54
224
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.6
7.0
138
2112
N07BC02
ATC
methadone; systemic
8.8
7.0
14
16
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
7.0
94
1569
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.5
6.9
52
1021
L90
ICPC
Osteoarthrosis of knee
0.4
6.9
28
680
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.8
6.9
112
636
R96
ICPC
Asthma
0.5
6.8
40
853
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
0.5
6.8
52
1016
L01XE04
ATC
[U] sunitinib; oral
11.0
6.8
12
11
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
11.0
6.8
12
11
SPAT1290
SPAT
Preparation of deceased person
9.3
6.8
13
14
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.7
6.8
170
2472
C10AX09
ATC
ezetimibe; oral
0.5
6.8
71
1265
I50.1
ICD-10 Finland
Left ventricular failure
0.4
6.7
36
789
N02AA03
ATC
hydromorphone; systemic, rectal
7.2
6.7
15
21
SPAT1097
SPAT
Recording of ECG
0.6
6.7
140
2109
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.6
6.7
118
1846
322
Kela drug reimbursment
Sunitinib
22.6
6.7
9
*
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
6.6
76
1320
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
12.3
6.6
11
9
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
6.6
256
1823
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
6.9
6.5
15
22
ZYC01
SPAT
NA
0.3
6.5
11
396
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.7
6.5
195
2738
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.5
6.5
21
47
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.2
6.4
60
273
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.7
6.4
42
160
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
7.4
6.4
14
19
I50.0
ICD-10 Finland
Congestive heart failure
0.6
6.4
81
1369
M54.5
ICD-10 Finland
Low back pain
0.7
6.4
284
3737
L28
ICPC
Limited function/disability (L)
0.7
6.4
169
2430
ZXA05
NOMESCO Finland
Left side
0.7
6.3
293
3833
N05AX08
ATC
risperidone; systemic
0.5
6.3
54
1020
L12
ICPC
Hand/finger symptom/complaint
0.6
6.3
81
1368
L01BC04
ATC
carmofur; oral
11.0
6.3
11
10
XW2BT
NOMESCO Finland
Other cytological test with X-ray guidance
+∞
6.3
6
*
8151/3-C25.9
ICD-O-3
Insulinoma, NOS, of pancreas, NOS
+∞
6.3
6
*
8246/3-C25.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of tail of pancreas
+∞
6.3
6
*
8000/3-C25.8
ICD-O-3
Neoplasm, malignant of overlapping lesion of pancreas
+∞
6.3
6
*
D07AC01
ATC
betamethasone; topical
0.7
6.2
372
4692
S29
ICPC
Skin symptom/complaint other
0.6
6.2
134
2007
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.4
6.2
29
669
H25.0
ICD-10 Finland
Senile incipient cataract
0.5
6.2
37
781
WZA90
NOMESCO Finland
Other doctors statement
0.7
6.2
166
2385
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
6.2
231
3131
WX725
NOMESCO Finland
Noninvasive ventilation
2.0
6.2
73
371
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.2
718
6079
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
6.2
42
848
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
3.3
6.1
28
85
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
6.1
164
2355
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.8
6.1
36
130
SPAT1110
SPAT
Measurement of pain intensity
4.0
6.1
22
55
K56.7
ICD-10 Finland
Ileus, unspecified
2.5
6.1
45
186
J45.9
ICD-10 Finland
Asthma, unspecified
0.7
6.0
150
2188
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
512
397
16.25
307.65
6.7
2.9
u/ml
4708.0
379.5
4.19
478
371
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1136
2124
9.48
307.65
6.3
3.8
ug/l
76.9
21.9
1.26
1068
1775
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
733
704
14.73
307.65
7.0
2.9
u/ml
19374.1
598.3
1.53
672
599
(3000570) Elastase.pancreatic [Mass/mass] in Stool
589
501
15.39
307.65
1.6
1.4
ug/g
158.8
282.6
24.23
342
297
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
214
159
14.72
232.16
1.2
1.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
114
15
79.86
213.63
4.3
2.3
pmol/l
102.3
78.9
0.25
92
15
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
672
2024
4.26
199.60
5.5
2.5
umol/l
41.9
9.0
28.44
622
1776
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
608
1813
4.18
181.43
3.6
2.0
g/l
0.2
0.2
3.87
575
1680
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1176
5764
3.10
155.48
5.9
2.5
u/l
52.8
59.1
1.40
1114
5266
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
490
1674
3.44
115.13
7.2
2.3
u/l
121.9
34.4
0.73
450
1419
(40768441) Liver Pathology biopsy report
116
104
11.69
111.32
1.0
1.3
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
67
27
25.52
95.65
3.1
1.3
pmol/l
36.6
40.4
0.07
56
21
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1204
16762
0.42
91.23
3.8
5.3
mmol/l
2.5
2.6
1.90
1016
15042
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1132
16113
0.42
89.54
3.6
4.7
mmol/l
1.4
1.4
6.55
952
14423
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1154
16280
0.42
88.63
3.5
4.7
mmol/l
4.3
4.4
2.48
977
14705
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1116
15585
0.46
74.20
3.4
4.2
mmol/l
1.3
1.3
2.26
937
13813
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1236
16579
0.46
72.26
4.6
5.0
mmol/l
6.9
6.1
29.99
1075
14691
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1415
9722
2.16
68.76
23.7
5.9
umol/l
24.3
12.1
19.67
1365
9187
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1109
15327
0.47
67.24
3.8
4.7
mu/l
2.1
2.1
0.12
932
13634
(3023368) Bacteria identified in Blood by Culture
985
6005
2.11
64.29
6.7
4.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
887
5268
2.10
61.37
6.7
3.0
u/l
62.2
34.3
19.22
849
4986
(3024561) Albumin [Mass/volume] in Serum or Plasma
1255
8476
2.04
60.85
12.1
4.7
g/l
31.0
34.5
71.72
1207
7810
(3000963) Hemoglobin [Mass/volume] in Blood
1502
18432
0.48
58.10
51.1
25.5
g/l
119.2
132.7
189.56
1454
18026
(3007461) Platelets [#/volume] in Blood
1501
18423
0.48
58.06
50.8
25.4
e9/l
257.0
240.2
11.06
1446
17826
(3010813) Leukocytes [#/volume] in Blood
1502
18430
0.48
58.02
50.7
25.4
e9/l
7.7
6.9
22.37
1436
17751
(3026361) Erythrocytes [#/volume] in Blood
1502
18428
0.48
57.94
50.7
25.3
e12/l
4.0
4.4
133.89
1438
17744
(3024731) MCV [Entitic volume]
1502
18427
0.48
57.90
50.6
25.3
fl
91.2
91.7
4.16
1456
18022
(3035941) MCH [Entitic mass]
1502
18426
0.48
57.86
50.5
25.2
pg
30.1
30.4
11.02
1455
18022
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1205
15823
0.51
55.18
35.7
16.4
ml/min/173m2
81.9
72.8
42.55
1091
13130
(4035726)
368
1576
2.59
54.52
1.3
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1233
15949
0.52
51.30
7.6
6.5
mmol/mol
46.3
41.0
37.45
1124
14437
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
873
12512
0.52
49.68
3.4
3.9
pmol/l
15.1
15.1
0.09
744
11054
(3032080) INR in Blood by Coagulation assay
1198
8482
1.85
45.21
11.1
11.3
inr
1.3
1.4
2.30
300
2278
(3023103) Potassium [Moles/volume] in Serum or Plasma
1492
17980
0.53
44.50
38.6
20.8
mmol/l
4.0
4.0
9.79
1443
17422
(3019550) Sodium [Moles/volume] in Serum or Plasma
1492
17947
0.53
43.41
38.9
20.6
mmol/l
137.7
139.6
87.95
1444
17417
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1479
17826
0.53
43.05
27.6
11.0
u/l
42.6
25.2
46.44
1431
17009
(3014576) Chloride [Moles/volume] in Serum or Plasma
486
2598
2.10
41.99
8.4
6.4
mmol/l
103.7
104.3
2.63
480
2524
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
175
4409
0.35
41.85
1.6
1.6
mmol/l
1.4
1.3
0.18
157
3639
(40762365) Oxygen content in Arterial blood by calculation
45
42
10.91
41.81
6.0
2.3
ml/dl
13.6
15.4
2.49
45
37
(3033658) Prothrombin time (PT) actual/Normal
739
4627
1.87
40.14
6.7
4.0
%
77.7
84.2
11.30
724
4505
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
123
346
3.70
37.61
1.7
1.6
nmol/l
0.6
0.9
2.94
111
274
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
513
8203
0.52
36.72
2.6
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1449
17299
0.57
35.06
31.8
16.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
485
2764
1.95
34.32
2.1
2.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
985
12939
0.59
33.64
3.1
4.2
mm/h
18.1
14.5
7.49
876
11804
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
610
3856
1.79
30.67
9.8
3.0
mmol/l
2.5
2.5
8.51
579
3363
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
70
152
4.72
30.20
1.5
1.2
nmol/l
1.2
1.5
1.08
62
132
(3044640) Blood type and Crossmatch panel - Blood
849
5922
1.68
29.78
3.3
2.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
122
405
3.12
28.72
1.9
2.5
umol/l
42.5
34.0
2.08
88
330
(3024980) IgG subclass 4 [Mass/volume] in Serum
83
215
3.97
28.54
1.5
1.6
g/l
0.9
0.9
0.09
55
167
(3023487) Leukocytes [#/volume] in Peritoneal fluid
45
69
6.63
28.13
1.4
2.3
e6/l
10459.1
844.2
0.57
33
57
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
383
6311
0.53
28.05
3.6
4.7
%
21.2
21.9
0.38
173
3294
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
526
7860
0.57
27.04
3.6
5.3
ug/l
2.9
4.4
1.49
426
6913
(3012095) Magnesium [Moles/volume] in Serum or Plasma
510
3178
1.77
26.39
3.7
3.1
mmol/l
0.8
0.8
1.14
482
2934
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
581
8396
0.59
25.92
2.0
2.1
pmol/l
90.8
92.9
0.52
363
4386
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
369
6020
0.54
25.59
1.9
2.2
u/l
167.0
220.8
1.32
334
5623
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
286
1495
2.04
25.34
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
181
814
2.33
23.38
2.4
2.6
u/ml
0.3
0.3
1.59
108
468
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
4481
0.51
22.39
2.6
3.3
ug/l
0.7
0.8
1.07
163
3154
(3009542) Hematocrit [Volume Fraction] of Blood
1236
14703
0.66
20.75
36.2
18.8
%
34.7
38.5
23.32
750
9095
(3033799) Differential panel - Peritoneal fluid
35
59
6.01
19.97
1.5
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1489
17010
0.65
19.91
37.0
17.4
mg/l
40.5
27.4
33.83
1415
13955
(3026493) Urate [Moles/volume] in Serum or Plasma
307
4964
0.56
19.56
2.6
2.9
umol/l
4116.9
6970.1
0.48
241
4196
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
35
61
5.81
19.31
1.2
2.1
e6/l
17971.1
30571.1
0.16
21
37
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
192
962
2.09
18.94
2.2
1.9
ug/l
1.6
2.5
0.47
172
829
(3013650) Neutrophils [#/volume] in Blood by Automated count
1225
10008
1.47
18.26
25.4
8.5
e9/l
4.6
4.3
2.65
1142
8674
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1059
8411
1.47
18.23
5.5
4.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
42
91
4.68
18.23
1.3
1.3
nmol/l
0.9
1.0
0.33
36
66
(1761868) Lipid panel - Serum or Plasma
297
4765
0.57
18.17
3.0
3.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
109
438
2.56
18.00
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1128
13458
0.69
17.34
47.0
22.9
g/l
329.5
331.4
10.31
1101
13293
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
108
2364
0.43
16.93
1.1
1.2
u/ml
9.6
13.7
0.26
38
836
(3002385) Erythrocyte distribution width [Ratio]
1132
13470
0.69
16.92
45.8
21.0
%
15.1
13.9
88.88
1108
13111
(3015377) Calcium [Moles/volume] in Serum or Plasma
852
6561
1.47
16.76
10.1
3.3
mmol/l
2.3
2.3
8.43
803
5593
(40758558) Short blood count panel - Blood
608
4392
1.52
16.30
20.1
6.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
324
4960
0.60
16.24
1.6
1.6
nmol/l
20.7
20.1
0.34
304
4164
(3044889) 12 lead EKG panel
1041
12530
0.69
16.22
4.3
4.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
121
2454
0.47
15.39
1.1
1.2
iu/ml
38.9
39.3
0.01
30
784
(3044007) Cell count panel - Peritoneal fluid
29
53
5.53
15.25
1.2
2.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
532
7197
0.66
15.10
2.4
2.2
nmol/l
69.0
78.9
12.63
486
6237
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
124
580
2.20
14.59
1.9
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
450
3128
1.54
14.17
2.1
2.0
s
30.4
30.1
0.32
442
3029
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
65
228
2.90
14.00
1.1
1.1
iu/ml
29.1
58.9
—
8
42
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
73
278
2.68
13.49
5.7
6.3
mg/l
11.7
12.3
0.48
63
257
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
610
4557
1.46
13.43
2.9
2.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
503
6685
0.68
12.39
2.4
3.2
ng/l
1279.3
1956.9
3.84
443
5787
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
24
45
5.38
12.30
1.3
2.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
382
2665
1.52
11.64
3.3
5.4
mmol/l
1.0
1.0
2.58
359
2439
(3041354) Potassium [Moles/volume] in Venous blood
71
295
2.45
11.03
3.1
2.5
mmol/l
4.0
4.1
1.13
71
290
(3035285) Chloride [Moles/volume] in Venous blood
71
295
2.45
11.03
3.1
2.5
mmol/l
103.5
105.5
2.64
71
290
(3004588) Protein electrophoresis panel - Serum or Plasma
73
1566
0.45
10.70
1.8
2.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
69
290
2.42
10.48
3.2
2.5
—
—
—
0
0
(3020891) Body temperature
152
861
1.82
10.46
6.0
4.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
98
480
2.09
10.32
5.6
5.1
mmol/l
3.0
2.7
0.63
76
330
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
139
2355
0.56
9.79
3.3
4.8
%
33.1
33.3
0.04
81
1504
(3012516) Albumin [Mass/volume] in Urine
448
5868
0.71
9.63
2.6
3.2
mg/l
83.6
289.6
3.54
285
3756
(3026782) Osmolality of Urine
522
4014
1.39
9.28
2.9
2.9
mosm/kgh2o
552.7
554.3
0.06
467
3406
(3003694) ABO and Rh group [Type] in Blood
542
4197
1.38
9.23
1.4
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
205
1306
1.62
9.23
6.4
8.4
%
94.2
93.7
0.55
205
1298
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
84
415
2.06
8.70
1.8
2.3
%
234.2
206.6
1.74
75
392
(3008152) Bicarbonate [Moles/volume] in Arterial blood
212
1384
1.58
8.63
9.7
6.5
mmol/l
24.5
24.5
0.06
201
1289
(4062490)
38
131
2.93
8.55
1.2
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29
85
3.44
8.50
2.4
1.6
nmol/l
16.1
16.2
0.04
29
75
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
198
1282
1.60
8.35
1.8
1.5
—
—
—
0
0
(3010421) pH of Blood
104
563
1.89
8.31
5.5
4.8
ph
7.4
7.4
0.75
97
470
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
1243
0.46
8.24
1.9
2.2
nmol/l
11.4
12.3
0.40
54
1065
(3027135) IgG subclass 1 [Mass/volume] in Serum
37
129
2.90
8.18
1.2
1.3
g/l
6.6
7.4
0.55
18
92
(3028192) IgG subclass 2 [Mass/volume] in Serum
37
129
2.90
8.18
1.2
1.3
g/l
3.4
2.9
1.59
18
94
(3024139) IgG subclass 3 [Mass/volume] in Serum
37
129
2.90
8.18
1.2
1.3
g/l
0.5
0.4
0.10
18
92
(3045414) Leukocytes [Presence] in Urine
28
802
0.34
8.08
2.0
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
579
7131
0.75
8.05
2.3
2.8
ug/l
252.1
155.8
5.16
533
6410
(40768443) Skin Pathology biopsy report
28
792
0.35
7.88
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
27
80
3.40
7.80
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
473
5956
0.74
7.57
2.6
3.1
mmol/l
6.8
7.2
1.61
371
4898
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
496
0.20
7.53
1.8
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
217
1486
1.51
7.13
7.0
4.3
—
—
—
0
0
(3000492) Spirometry study
72
1342
0.52
7.02
1.4
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
113
1849
0.59
6.94
1.6
2.7
g/l
63.9
65.9
1.77
102
1670
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
775
0.39
6.70
1.6
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1248
11159
1.25
6.70
7.5
4.8
mmol/l
8.0
6.9
32.76
1199
10510
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
56
264
2.15
6.63
1.3
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
696
5822
1.28
6.55
6.0
4.0
ph
7.4
7.4
0.93
166
1105
(4281824)
40
164
2.46
6.52
1.4
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
88
491
1.82
6.46
10.7
6.2
mmol/l
10.7
11.2
1.33
79
441
(3018572) Chloride [Moles/volume] in Blood
88
491
1.82
6.46
10.7
6.2
mmol/l
106.0
105.3
0.73
79
441
(3035350) Ketones [Presence] in Urine by Test strip
733
8576
0.79
6.46
3.7
4.0
estimate
0.0
0.0
0.00
177
1629
(3037522) Nuclear Ab [Titer] in Serum
121
1910
0.61
6.42
1.2
1.3
titre
377.1
528.0
0.59
21
431
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
24
76
3.18
6.29
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
24
76
3.18
6.29
1.1
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
358
0.25
6.28
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
88
1497
0.57
6.27
1.4
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
275
2020
1.41
6.27
7.7
7.4
g/l
114.1
120.3
6.56
265
1941
(3020682) Albumin/Creatinine [Ratio] in Urine
509
6207
0.77
6.22
3.4
4.0
mg/mmol
13.7
9.1
0.84
308
3957
(3021601) Nitrite [Presence] in Urine by Test strip
737
8581
0.79
6.13
5.0
5.4
estimate
0.0
0.0
0.00
174
1628
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1016
8939
1.24
6.07
7.4
5.9
mmol/l
1.2
1.2
7.36
958
7982
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
50
235
2.15
5.99
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
751
8696
0.80
5.87
3.8
4.1
estimate
0.0
0.0
0.80
167
1585
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
866
0.46
5.83
1.4
2.5
g/l
7.8
7.4
0.73
33
642
(3020779) Urea [Moles/volume] in Serum or Plasma
257
1890
1.40
5.82
3.4
6.7
mmol/l
8.1
11.2
10.53
237
1783
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
865
0.46
5.82
1.4
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
864
0.47
5.80
1.4
2.5
g/l
3.8
3.8
0.10
33
620
(3002032) Base excess in Venous blood by calculation
266
1979
1.39
5.63
3.0
3.4
mmol/l
2.1
2.0
0.12
211
1554
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
78
439
1.80
5.61
1.3
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
267
1992
1.38
5.55
3.0
3.4
kpa
5.6
5.8
5.40
257
1923
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
81
464
1.77
5.50
1.3
1.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
29
111
2.63
5.48
1.1
1.2
mmol/l
11.3
12.0
0.18
21
32
(21494755) Public health laboratory ask at order entry panel
26
637
0.40
5.42
1.1
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
124
1862
0.65
5.28
1.2
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
105
654
1.63
5.27
5.2
3.9
mmol/l
3.9
3.9
0.15
99
600
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62
333
1.89
5.20
1.3
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
223
1645
1.39
4.97
2.9
2.8
kpa
4.5
4.5
0.09
214
1580
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
106
673
1.60
4.94
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
39
180
2.19
4.94
2.2
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
296
0.27
4.93
1.5
1.8
—
—
—
0
0
(3012544) pH of Venous blood
270
2059
1.35
4.90
3.2
3.4
—
7.4
—
0
10
(3013512) EKG study
488
5837
0.79
4.88
4.3
4.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
355
4408
0.77
4.82
1.8
1.8
nmol/l
1248.9
1178.6
0.77
288
3255
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
105
671
1.59
4.78
1.6
3.9
u/ml
207.7
71.5
1.80
98
647
(40760888) Immunoglobulin light chains.free panel - Serum
24
570
0.42
4.69
1.8
3.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
693
5979
1.23
4.68
3.2
3.5
e6/l
26.4
91.9
5.75
573
4697
(3016650) Hepatitis A virus Ab [Presence] in Serum
45
226
2.01
4.61
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
14
421
0.33
4.60
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
182
2474
0.71
4.58
15.8
8.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
139
1974
0.69
4.49
2.1
2.4
e9/l
70.1
68.3
0.18
110
1524
(3011397) Hemoglobin [Presence] in Urine by Test strip
336
4164
0.77
4.47
3.4
3.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
35
162
2.18
4.44
1.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
43
216
2.01
4.42
1.3
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
104
677
1.56
4.40
10.1
5.7
mmol/l
1.5
1.3
1.10
91
596
(3051651) Icteric interference index of Serum or Plasma
28
118
2.39
4.40
5.6
3.5
—
—
—
0
0
(4010399)
80
1265
0.62
4.33
1.2
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
284
2223
1.32
4.32
7.5
6.9
%
96.3
95.2
1.86
273
2135
(3008898) HLA-B27 [Presence]
10
343
0.29
4.24
1.0
1.1
—
—
—
0
0
(4094501)
17
445
0.38
4.20
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1138
12396
0.84
4.19
3.9
4.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
542
0.44
4.17
1.2
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1080
9800
1.19
4.15
8.1
6.7
mmol/l
1.2
1.2
4.70
882
8178
(3038515) Glucose [Moles/volume] in Venous blood
77
474
1.65
4.12
3.9
3.4
mmol/l
9.6
7.9
3.29
77
464
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
468
0.40
4.09
1.3
1.6
iu/ml
43.8
12.6
—
8
109
(40768800) Prostate Pathology biopsy report
21
495
0.42
4.07
1.1
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
658
7512
0.83
4.07
19.0
10.3
e9/l
0.0
0.0
1.50
532
6092
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
314
2513
1.29
4.05
1.8
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
59
340
1.75
4.02
3.6
3.5
%
60.9
59.3
0.44
59
340
(21494434) Karyotype in Bone marrow
5
210
0.24
3.96
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
346
2814
1.27
3.92
2.0
2.6
%
18.8
22.1
3.66
296
2365
(3008037) Lactate [Moles/volume] in Venous blood
80
504
1.61
3.92
3.8
3.3
mmol/l
1.8
1.7
0.30
80
492
(3037756) Immunofixation for Serum or Plasma
24
527
0.45
3.90
1.1
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
16
54
2.98
3.85
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
453
0.41
3.81
2.3
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
36
180
2.02
3.79
1.9
1.2
nmol/l
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
362
2975
1.26
3.76
1.9
2.5
g/l
2.2
2.3
1.37
340
2733
(3038177) Helicobacter pylori Ab [Presence] in Serum
36
181
2.00
3.74
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
78
495
1.60
3.73
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
78
495
1.60
3.73
1.3
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
584
0.49
3.72
3.0
3.2
nmol/l
0.8
0.8
0.62
23
449
(3036489) Thrombin time
92
609
1.53
3.67
1.7
1.9
s
23.4
21.8
1.02
84
549
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
142
2.13
3.65
1.2
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
386
3207
1.24
3.64
2.0
2.5
umol/l
10.1
12.2
7.35
369
2950
(3007164) IgA [Mass/volume] in Serum or Plasma
214
2737
0.76
3.60
1.4
1.4
g/l
2.6
2.7
0.35
121
1572
(3044290) Cell count panel - Cerebral spinal fluid
10
311
0.32
3.58
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
323
0.34
3.52
1.4
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
125
1727
0.71
3.49
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
309
2520
1.26
3.43
1.8
1.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
147
1085
1.38
3.34
3.5
3.1
mmol/l
24.3
25.1
2.09
140
1051
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
152
1131
1.37
3.29
9.6
9.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
303
2486
1.25
3.20
7.3
6.6
mmol/l
1.4
1.2
0.54
251
1907
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
406
0.44
3.19
1.1
1.2
—
48.1
—
0
23
(3030905) Polymorphonuclear cells [#/volume] in Blood
54
326
1.67
3.18
3.0
3.2
e9/l
4.8
4.5
0.29
54
326
(3030467) Casts [#/volume] in Urine by Automated count
617
5447
1.18
3.07
3.1
3.4
e6/l
0.6
0.5
0.68
512
4219
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
12
5.85
3.02
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
117
847
1.40
3.01
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
376
4416
0.82
3.01
1.6
1.7
pmol/l
469.4
18317403.6
2.35
296
3565
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
113
2.14
3.00
1.9
1.8
u/l
8350.0
1569.0
—
9
38
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
462
0.49
2.99
1.3
1.7
—
—
—
0
0
(4024509)
6
194
0.31
2.93
1.2
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
35
191
1.85
2.93
1.9
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
799
0.62
2.92
1.1
1.2
iu/ml
244.6
139.8
0.68
20
275
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
34
597
0.56
2.87
1.4
1.6
—
120.6
—
0
31
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
64
2.51
2.87
1.3
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
372
0.45
2.82
1.6
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
299
2485
1.23
2.82
7.3
6.6
kpa
5.0
5.1
1.00
287
2349
(3027801) Oxygen [Partial pressure] in Arterial blood
299
2485
1.23
2.82
7.3
6.6
kpa
13.5
11.8
6.22
287
2352
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
47
2.78
2.81
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
47
284
1.67
2.80
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
207
0.34
2.78
1.1
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
133
998
1.35
2.77
4.0
3.7
%
53.7
47.5
2.50
133
984
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
253
3068
0.80
2.76
1.2
1.2
u/ml
4.7
1.6
0.68
59
762
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
25
473
0.52
2.73
1.1
1.4
—
17.6
—
0
11
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
638
0.59
2.73
1.2
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
64
953
0.66
2.73
2.9
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
27
495
0.54
2.67
2.9
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
48
296
1.63
2.66
1.2
1.4
e6/l
30192.9
78583.4
1.09
33
172
(3048689) Calprotectin [Mass/mass] in Stool
123
1626
0.74
2.65
1.6
2.1
ug/g
124.5
151.2
0.32
99
1269
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
417
3603
1.19
2.64
1.9
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
84
589
1.44
2.62
4.6
4.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
36
207
1.75
2.58
1.9
1.2
nmol/l
0.6
0.7
0.66
31
192
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
17
358
0.47
2.57
1.0
1.2
—
316.0
—
0
10
(3019832) Treponema pallidum Ab [Presence] in Serum
29
514
0.56
2.56
1.3
1.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
119
891
1.35
2.54
9.0
4.8
%
0.9
0.9
0.99
109
837
(40768793) Breast Pathology biopsy report
15
329
0.45
2.54
1.3
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
120
1580
0.75
2.53
4.0
3.7
ng/l
83.1
95.6
0.86
99
1327
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
120
901
1.35
2.52
8.9
4.8
%
1.7
1.6
0.26
109
846
(3023199) Leukocytes [#/volume] in Pleural fluid
51
325
1.58
2.50
1.2
1.4
e6/l
2913.1
1746.3
0.58
42
234
(44790049)
35
202
1.74
2.48
1.3
1.5
—
—
—
0
0
(44790047)
35
202
1.74
2.48
1.3
1.5
—
—
—
0
0
(44806118)
35
202
1.74
2.48
1.3
1.5
—
—
—
0
0
(44790048)
35
202
1.74
2.48
1.3
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
127
966
1.33
2.45
2.4
3.6
mmol/l
24.7
24.1
0.95
119
857
(3045788) Cell count panel - Pleural fluid
42
257
1.65
2.42
1.3
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1083
10097
1.14
2.42
5.4
3.1
u/l
237.2
55.0
42.24
1023
9202
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
64
0.00
2.42
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
65
0.00
2.41
0.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
205
0.39
2.41
1.0
1.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
53
344
1.55
2.41
2.4
3.8
%
1.1
1.7
1.17
44
262
(3027945) Reticulocytes/100 erythrocytes in Blood
218
2645
0.81
2.40
2.1
2.4
%
1.9
1.8
0.92
203
2304
(3019150) Specific gravity of Urine by Refractometry
330
3841
0.84
2.38
4.0
4.5
kg/l
1.0
1.0
0.17
61
598
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
469
5292
0.86
2.32
2.0
2.3
mg/l
3.2
3.1
0.27
407
4445
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
35
207
1.70
2.30
2.0
1.2
nmol/l
0.2
0.4
—
5
15
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
252
2104
1.22
2.30
5.9
3.9
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
59
397
1.50
2.29
1.1
1.1
titre
108.3
91.7
—
6
24
(3014111) Lactate [Moles/volume] in Serum or Plasma
221
1822
1.24
2.28
4.0
6.3
mmol/l
1.6
1.4
1.94
213
1742
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
317
1.56
2.28
1.3
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
585
5254
1.15
2.27
3.1
3.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
33
544
0.60
2.26
2.7
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
106
1.99
2.25
1.3
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
106
1.99
2.25
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
41
255
1.62
2.24
1.3
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
78
1072
0.72
2.20
1.3
1.7
g/l
1.6
1.5
0.32
66
905
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
165
0.36
2.14
1.0
1.1
—
2.6
—
0
5
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
773
7106
1.13
2.09
3.2
3.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
55
0.00
2.06
0.0
1.1
—
14.6
—
0
9
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
164
2012
0.80
2.03
2.1
2.5
ug/l
3.0
7.2
11.21
139
1718
(36660697) Celiac disease serology panel - Serum
82
1101
0.74
2.02
1.2
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
178
0.39
2.02
1.1
1.9
—
1.1
—
0
7
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
44
2.51
2.01
1.4
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
11
44
2.51
2.01
1.3
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
206
1713
1.22
1.98
4.5
7.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
183
1504
1.24
1.97
3.4
4.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
53
362
1.47
1.96
1.2
1.5
g/l
35.6
30.9
1.10
47
328
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
570
0.64
1.94
1.4
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
21
114
1.85
1.87
1.1
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
197
1642
1.22
1.87
7.1
3.8
mmol/l
1.2
1.2
0.81
185
1416
(3017704) Immunofixation for Urine
5
143
0.35
1.87
1.2
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
476
4277
1.14
1.82
2.6
2.8
e6/l
6.8
4.8
1.96
436
3765
(21494890) Protein electrophoresis panel - 24 hour Urine
11
234
0.47
1.79
1.6
2.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
166
0.42
1.78
1.0
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
21
116
1.82
1.78
3.6
3.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
112
1411
0.78
1.77
2.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
135
0.37
1.75
1.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
138
0.36
1.74
1.0
1.4
—
247.3
—
0
15
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
24
2.92
1.72
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
394
0.61
1.69
2.1
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
147
0.41
1.64
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
328
0.58
1.63
1.5
1.7
iu/l
2.5
4.6
—
9
106
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
14
3.58
1.61
1.2
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
254
1.50
1.60
1.3
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
128
1.73
1.60
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
123
1510
0.80
1.58
1.4
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
26
2.70
1.58
1.1
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
327
3683
0.87
1.57
1.5
1.7
mg/l
3.3
1.5
3.49
272
2880
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
57
2.11
1.55
2.3
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
78
1.93
1.54
3.8
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1451
13966
1.10
1.52
25.4
7.4
u/l
192.7
80.6
78.56
1403
13031
(42870588) Differential panel, method unspecified - Blood
657
6081
1.11
1.52
5.0
5.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
43
0.00
1.52
0.0
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
43
0.00
1.52
0.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
731
7832
0.90
1.51
3.6
4.2
ng/l
37.6
59.5
1.30
595
6037
(3023420) DNA double strand Ab [Units/volume] in Serum
6
143
0.42
1.51
1.2
1.3
—
30.4
—
0
9
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
64
848
0.75
1.51
2.1
3.1
pmol/l
4.2
4.3
0.54
56
732
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
21
2.86
1.50
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
162
1359
1.21
1.49
1.3
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
37
2.44
1.48
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
166
0.48
1.47
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
75
967
0.77
1.46
1.5
1.7
g/l
1.0
1.5
3.80
69
868
(3024891) Influenza virus A+B Ag [Presence] in Specimen
57
420
1.37
1.46
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
253
0.55
1.44
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
276
2435
1.15
1.40
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
176
2058
0.84
1.39
3.8
4.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
52
700
0.74
1.39
1.7
3.0
g/l
0.3
0.3
0.00
24
269
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
121
0.41
1.37
1.0
1.2
mmol/l
3.0
2.1
—
5
112
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
236
0.55
1.37
2.8
3.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
16
273
0.58
1.35
1.1
1.2
—
42.5
—
0
26
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
8
164
0.49
1.35
1.1
2.0
mg/l
3.8
4.6
—
8
159
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
37
0.00
1.34
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
20
120
1.67
1.34
3.1
2.8
ph
7.4
7.4
—
8
39
(3000285) Sodium [Moles/volume] in Blood
0
39
0.00
1.33
0.0
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
39
0.00
1.33
0.0
1.3
—
126.0
—
0
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
216
1.49
1.33
3.0
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
168
1432
1.19
1.32
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
1106
0.80
1.31
2.5
2.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
24
2.50
1.30
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
107
1301
0.81
1.30
3.3
3.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
330
0.63
1.29
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
92
1134
0.80
1.27
4.1
3.3
e9/l
4.2
4.2
0.08
70
816
(3008295) Osmolality of Serum or Plasma
29
194
1.50
1.27
1.3
1.3
mosm/kgh2o
275.4
277.5
0.23
24
131
(3018095) Leukocytes [#/volume] in Urine
722
6772
1.10
1.26
3.6
4.0
e6/l
66.4
134.4
3.00
581
5015
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
19
2.63
1.21
3.2
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
175
2013
0.86
1.16
1.7
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
128
0.47
1.16
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
111
0.45
1.13
1.0
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
57
442
1.30
1.10
2.5
2.6
%
13.8
15.9
1.51
16
221
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
21
2.38
1.09
1.8
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
34
467
0.72
1.08
2.3
2.2
g/l
114.7
127.6
1.83
22
344
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
34
244
1.40
1.07
1.1
1.3
u/ml
103.6
131.5
—
7
47
(3045142) Bone marrow Pathology biopsy report
14
226
0.62
1.01
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
157
0.57
0.98
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
68
837
0.81
0.98
1.7
1.9
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
2.3
—
40.6
—
0
23
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
132
1.52
0.97
1.1
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.6
—
2.4
—
0
21
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
223
0.63
0.96
1.6
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
223
0.63
0.96
1.4
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
619
6559
0.92
0.96
4.0
4.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
9
52
1.73
0.92
1.2
1.6
pmol/l
15.2
14.6
—
9
37
(3003327) Ova and parasites identified in Stool by Light microscopy
32
429
0.74
0.91
1.6
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
143
1633
0.87
0.90
1.6
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
344
3168
1.10
0.90
3.0
3.1
e6/l
3.3
1.9
1.34
204
1794
(3000093) Morphology [Interpretation] in Blood Narrative
12
194
0.62
0.89
1.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
13
79
1.65
0.88
1.3
1.5
%
42.4
23.5
1.16
13
73
(4268621)
7
130
0.54
0.87
1.9
2.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
321
0.71
0.85
1.3
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
112
0.53
0.83
1.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
112
0.53
0.83
1.2
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
171
1.41
0.83
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
171
1.41
0.83
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
171
1.41
0.83
1.2
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
113
0.53
0.83
2.2
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
46
1.74
0.82
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
482
1.23
0.80
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
49
392
1.26
0.80
1.4
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
167
1491
1.13
0.79
2.8
2.1
nmol/l
420.1
372.6
2.07
155
1342
(3021901) Oxygen saturation in Capillary blood
32
418
0.76
0.78
2.8
3.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
98
0.51
0.78
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
98
0.51
0.78
1.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
124
0.56
0.77
34.9
14.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
83
974
0.85
0.77
2.9
3.8
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
27
0.00
0.77
0.0
1.3
—
6.6
—
0
14
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
360
0.75
0.77
1.6
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
140
1.43
0.77
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
59
485
1.22
0.76
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
58
476
1.22
0.76
3.5
4.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
58
477
1.22
0.75
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
267
0.71
0.75
1.9
2.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
47
378
1.25
0.74
1.2
1.3
mmol/l
69.4
61.6
0.47
36
303
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
68
1.62
0.71
1.5
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
68
1.62
0.71
1.5
2.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
11
68
1.62
0.71
3.8
4.3
%
66.1
52.7
1.49
11
63
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
282
1.28
0.71
1.1
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
58
1.55
0.69
1.7
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
27
1.85
0.68
1.8
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
296
0.74
0.68
1.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
93
0.54
0.67
2.4
3.7
%
13.7
13.3
—
5
93
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
94
0.53
0.66
1.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
16
111
1.44
0.66
1.6
2.1
min
416.0
487.6
—
10
77
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
113
1275
0.88
0.65
2.8
3.7
mmol/l
2.2
1.9
0.18
79
936
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
120
1348
0.88
0.65
2.7
3.8
kpa
5.1
5.2
0.53
104
1232
(3013115) Eosinophils [#/volume] in Blood
857
8872
0.95
0.64
5.2
5.7
e9/l
0.2
0.2
2.86
746
7668
(3004775) Volume in Urine collected for unspecified duration
21
155
1.36
0.63
2.0
2.3
ml
622.9
626.3
0.01
13
95
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
138
1.38
0.62
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
377
3999
0.93
0.62
3.5
4.2
ng/l
102.6
597.5
1.59
297
3454
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
103
0.58
0.62
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
139
0.65
0.60
1.2
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
12
175
0.68
0.60
1.1
1.2
—
65.6
—
0
10
(4306422)
12
175
0.68
0.60
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
4.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
218
1.29
0.60
5.8
3.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
119
1329
0.89
0.60
2.8
3.8
ph
7.4
7.4
2.03
12
161
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
183
1.31
0.59
1.2
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
203
2203
0.91
0.59
1.6
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
226
2440
0.92
0.59
2.6
4.0
u/l
277.7
248.5
0.89
213
2281
(40758292) HTLV I+II Ab panel - Serum
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(44806420)
12
81
1.48
0.57
2.4
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
129
1428
0.90
0.56
2.6
4.0
%
0.1
0.1
0.02
80
441
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
87
0.57
0.56
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
71
814
0.87
0.54
3.0
4.1
mmol/l
24.7
24.9
0.17
62
739
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
66
1.52
0.52
1.3
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
69
601
1.15
0.52
5.2
3.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
169
0.71
0.52
1.0
1.1
—
—
—
0
0
(4034850)
49
575
0.85
0.51
14.4
12.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
36
297
1.22
0.50
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
280
0.78
0.50
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
291
0.79
0.50
1.6
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
171
1.29
0.49
1.2
1.2
u/l
53.3
51.2
0.12
17
118
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
53
615
0.86
0.49
1.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
107
0.65
0.48
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
107
0.65
0.48
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
107
0.65
0.48
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
109
0.64
0.48
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
109
0.64
0.48
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
109
0.64
0.48
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
46
1.52
0.48
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
81
909
0.89
0.47
1.7
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
427
4463
0.95
0.46
3.6
3.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
49
1.43
0.46
1.0
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
94
1.39
0.46
1.8
2.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
82
0.61
0.45
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
41
481
0.85
0.44
3.1
3.7
mg/l
42.9
29.0
1.24
31
312
(3011648) Oxygen content in Venous blood
19
148
1.29
0.43
1.3
1.7
%
11.6
10.7
0.40
19
148
(3026008) Bacteria identified in Urine by Culture
603
6234
0.96
0.43
3.1
3.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
218
0.78
0.42
1.1
1.4
—
—
—
0
0
(4211845)
6
93
0.64
0.42
3.0
3.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
87
1.38
0.42
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
190
2030
0.93
0.42
2.7
3.1
ng/l
214.1
248.2
0.57
173
1865
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
95
0.63
0.42
1.5
1.1
mg/l
84.1
42.8
—
6
82
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
4.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.7
—
15.2
—
0
17
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
195
1.23
0.40
1.2
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
159
1707
0.93
0.40
3.4
3.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
855
8763
0.96
0.40
5.3
5.6
e9/l
1.6
1.9
7.52
749
7592
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
132
1424
0.92
0.38
1.3
1.7
%
1.6
1.6
0.15
100
1180
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
36
1.39
0.38
1.2
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
122
1320
0.92
0.38
2.6
4.1
%
0.0
0.4
0.74
70
365
(3004716) Salmonella sp identified in Stool by Organism specific culture
70
628
1.12
0.38
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
113
1040
1.09
0.38
1.1
1.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
12
89
1.35
0.38
1.4
1.6
%
1.9
2.4
0.21
12
77
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
125
1.28
0.37
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
19
153
1.24
0.35
1.1
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
145
0.76
0.34
1.1
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
45
1.33
0.33
2.7
2.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
50
562
0.89
0.33
2.8
3.4
mmol/l
24.9
25.1
0.09
41
484
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
403
0.87
0.33
1.3
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
177
0.79
0.33
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
166
0.78
0.33
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
339
0.85
0.33
1.1
1.3
—
—
—
0
0
(44813793)
6
87
0.69
0.33
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
48
428
1.12
0.30
2.6
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
55
1.27
0.30
1.3
3.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
102
1.28
0.30
1.3
1.6
u/l
5.5
7.6
—
6
52
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
112
1.25
0.28
1.6
2.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
844
8599
0.97
0.28
5.1
5.5
e9/l
0.0
0.0
0.61
719
7322
(3012441) Differential panel - Pleural fluid
32
280
1.14
0.27
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
119
0.76
0.27
1.1
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
14
113
1.24
0.26
1.5
1.5
umol/l
11.3
14.9
1.11
14
106
(3001604) Monocytes [#/volume] in Blood
841
8563
0.97
0.26
5.0
5.5
e9/l
0.6
0.6
1.18
713
7275
(40768806) Pleura Pathology biopsy report
32
281
1.14
0.26
1.4
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
15
182
0.82
0.26
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
132
1.21
0.25
1.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
465
4774
0.97
0.25
3.7
4.4
estimate
0.0
0.0
0.69
150
1540
(3002179) Metamyelocytes/100 leukocytes in Blood
128
1354
0.94
0.25
2.4
3.9
%
0.5
0.6
0.36
67
334
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
71
767
0.92
0.25
2.2
2.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
148
0.81
0.24
1.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
148
0.81
0.24
1.2
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
137
0.80
0.24
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
91
852
1.07
0.24
1.1
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
827
8132
1.03
0.23
5.3
6.1
%
8.6
9.0
1.77
780
7527
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
45
495
0.91
0.23
2.5
2.3
ug/min
127.3
97.1
0.24
26
289
(3014271) Vancomycin [Susceptibility]
17
143
1.19
0.23
2.5
3.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
115
1216
0.94
0.23
1.7
2.7
g/l
10.0
10.8
1.43
93
1098
(3003740) Influenza virus B Ag [Presence] in Specimen
11
136
0.81
0.23
1.2
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
146
0.82
0.22
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
231
0.86
0.22
1.2
1.1
—
—
—
0
0
(3036603) Volume of Urine
13
107
1.22
0.21
1.6
1.4
ml
1649.2
1781.3
—
5
26
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
42
1.19
0.21
12.0
7.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.1
—
5.1
—
0
5
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
10
0.00
0.21
0.0
1.9
—
1.8
—
0
10
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
12
0.00
0.21
0.0
5.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
283
0.88
0.21
1.1
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
8
103
0.78
0.21
1.9
2.7
—
38.3
—
0
41
(3051101) Glucose [Moles/volume] in Cord blood
5
43
1.16
0.21
4.8
6.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
105
0.76
0.21
1.0
1.1
—
—
—
0
0
(44806071)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
4.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3024316) Viscosity of Plasma
0
14
0.00
0.20
0.0
1.3
—
1.7
—
0
7
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.1
—
0
6
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
58
539
1.08
0.19
1.8
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
51
1.18
0.19
2.5
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
240
2328
1.03
0.18
1.5
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
233
1.12
0.17
1.1
1.2
u/ml
257.4
291.5
0.32
16
133
(3000034) Microalbumin [Mass/volume] in Urine
20
176
1.14
0.17
2.2
3.2
mg/l
19.3
26.6
0.32
14
138
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
29
320
0.91
0.17
2.7
3.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
184
0.87
0.17
1.0
1.2
u/ml
2.1
5.4
—
7
88
(3002030) Lymphocytes/100 leukocytes in Blood
839
8284
1.02
0.17
5.3
6.0
%
21.9
26.0
17.70
786
7620
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
63
1.11
0.17
1.0
1.3
—
—
—
0
0
(4027681)
5
69
0.72
0.17
1.8
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
349
3416
1.03
0.15
3.9
4.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
80
1.13
0.15
1.1
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
80
1.13
0.15
1.1
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
82
1.10
0.15
1.1
1.9
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
223
0.90
0.14
1.5
3.6
%
61.3
57.6
0.28
14
138
(3000330) Specific gravity of Urine by Test strip
103
1073
0.96
0.14
4.5
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
153
1481
1.04
0.14
5.2
3.0
ml/min/173m2
65.1
60.3
1.07
62
636
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
110
0.82
0.13
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
320
3139
1.02
0.13
15.8
30.0
inr
1.4
1.5
0.62
42
410
(3006504) Eosinophils/100 leukocytes in Blood
818
8101
1.02
0.12
5.1
5.8
%
2.4
2.8
5.63
773
7474
(3031040) Bacteria [#/volume] in Urine by Automated count
1216
12241
0.99
0.12
4.5
5.1
e6/l
426.0
1875.7
1.37
21
224
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
240
1.08
0.11
2.2
4.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
15
135
1.11
0.09
1.7
2.1
e9/l
1.1
1.0
—
10
77
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
48
458
1.05
0.09
1.3
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
55
1.09
0.09
1.7
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
6
56
1.07
0.08
2.7
2.0
%
3.7
6.7
—
6
51
(3028433) Virus identified in Specimen by Culture
7
64
1.09
0.08
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
215
0.93
0.07
1.4
1.4
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
6
75
0.80
0.07
1.3
1.2
ug/l
987.0
452.4
—
6
35
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
82
0.85
0.07
1.7
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
101
0.89
0.06
1.0
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
48
497
0.97
0.06
2.4
3.0
kpa
8.0
7.7
0.51
40
452
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
201
0.94
0.04
2.5
2.0
u/field
1.5
2.2
—
8
69
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
231
0.95
0.04
1.4
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
19
180
1.06
0.04
1.5
1.4
u/l
12.1
14.0
0.92
19
170
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
119
0.92
0.04
1.5
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
121
1.07
0.03
3.8
2.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
150
1517
0.99
0.03
2.6
4.0
%
1.1
0.9
0.58
88
485
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
149
0.94
0.03
2.9
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
689
6868
1.00
0.03
2.6
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
251
1.04
0.02
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
321
1.03
0.02
1.1
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
117
0.94
0.01
3.0
2.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
123
1.06
0.01
4.8
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
186
0.97
0.00
2.6
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
20
194
1.03
0.00
1.6
1.3
pmol/l
313.0
276.2
0.25
15
146
(4146454)
22
225
0.98
0.00
2.4
2.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
231
1.00
0.00
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
231
1.00
0.00
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
231
1.00
0.00
1.4
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
309
1.00
0.00
2.0
2.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
10
104
0.96
0.00
2.0
2.0
—
44.5
—
0
15
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.1
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.1
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.1
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
814
8145
1.00
0.00
5.1
5.7
%
62.1
58.6
9.86
767
7539
(3022096) Basophils/100 leukocytes in Blood
788
7883
1.00
0.00
5.2
5.8
%
0.6
0.6
2.12
743
7277
(3017569) Oxygen content in Arterial blood
10
103
0.97
0.00
4.5
2.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
335
3353
1.00
0.00
2.9
2.9
e6/l
1.2
1.2
0.01
194
1971
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
213
0.99
0.00
1.2
1.3
miu/ml
177.7
206.6
—
6
74
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
233
0.99
0.00
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
233
0.99
0.00
1.4
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
64
0.94
0.00
1.3
1.5
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.7
—
23.6
—
0
7
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
222.8
—
0
6
(3045462) Protein/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
7.8
—
8.0
—
0
6
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.0
—
0
6
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
96
0.94
0.00
1.2
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
211.2
—
0
5
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
96
0.94
0.00
1.2
1.4
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.0
—
393.6
—
0
7
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.7
—
0
9
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
87
0.92
0.00
2.4
3.5
u/l
168.9
218.1
—
8
87
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.4
—
0
6
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
5.6
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.2
—
0
5
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
85
0.94
0.00
1.0
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
9
91
0.99
0.00
2.2
2.0
e9/l
0.1
0.1
—
9
86
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS – Malignant neoplasm of pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).